Medical Developments International (MDI)
Kelly Bovaird is an experienced National Key Account Manager in the retail sector, currently serving at Medical Developments International and US Drug and Device Register since October 2022. Previously, Kelly held senior positions at Fagron, Inc., including Sr. Director of Trade Relations and Director of Sales and Business Development, from September 2019 to June 2022. Prior experience also includes roles at HUMCO as Regional Director and Sales Representative, and an internship in Human Resources at CHC Helicopter. Additionally, Kelly contributed as an Assistant Coach at K-State Athletics from May 2015 to June 2016. Kelly holds a Bachelor's Degree in Social Sciences from Kansas State University.
This person is not in any offices
Medical Developments International (MDI)
"Delivering emergency medical solutions dedicated to improving patient outcomes" Medical Developments International (MDI) is one of Australia’s leading specialised healthcare companies. With an industry leading range of products in the areas of pain management, asthma and resuscitation, plus veterinary equipment, MDI has supplied healthcare professionals and patients innovative solutions since 1971. MDI is a publicly listed company on the Australian Stock Exchange (ASX) with both its head office and state of the art manufacturing facilities located in Victoria, Australia. MDI manufacture the innovative pain relief product, Penthrox® that has been widely adopted by organisations throughout Australia. MDI has a proud history in human and veterinary medicine, throughout Australia as well as internationally. For over 30 years MDI's key products have helped healthcare professionals achieve better health outcomes for their patients MDI is compliant with Good Manufacturing Practices as well as ISO 13485 for the manufacture of several of its products (including both pharmaceutical and medical products). Several MDI products are also CE marked, enabling them to be sold into the European Community.